You are here: Industry Insights > Clarivate

News List

Clarivate Identifies Seven Potential Blockbuster Drugs in Annual Drugs to Watch Report prnasia
January 10, 2022
Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the release of its annual Drugs to Watch™ report...
Clarivate Announces Expiration of its Private Exchange Offers for Two Series of Notes prnewswire
August 17, 2021
Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate") announced the expiration of two separate private offers to exchange (the "Exchange Offers"), by Clarivate Science Holdings Corporation.
Clarivate acquires analytics solutions provider in life sciences, Bioinfogate expresspharma
August 06, 2021
The acquisition will fill a critical need for drug toxicity data and translational safety intelligence across all stages of drug R&D.
Clarivate Acquires Bioinfogate, Reinforcing Position as Premier Provider of End-to-End Research Intelligence Solutions for Life Sciences prnasia
August 04, 2021
Clarivate Plc today announced that it has acquired Bioinfogate, a leading provider of analytics solutions in the life sciences and producer of the OFF-X™ portal. Financial terms of the transaction were not disclosed.  
New Centre for Medicines Research (CMR) Clinical Factbook From Clarivate Highlights Increasing Cost and Complexity of Phase II Trials prnasia
November 26, 2020
Clarivate Plc, a global leader in providing trusted information and insights to accelerate the pace of innovation, announced the release of the 2020 Centre for Medicines Research (CMR) International Pharmaceutical Clinical Factbook.